These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35345947)

  • 1. Kawasaki Disease with Peripheral and Facial Gangrene: A Case report and review of literature.
    Madan D; Maheshwari A; Mahto D; Mendiratta V; Sharma S
    Trop Doct; 2022 Jul; 52(3):449-452. PubMed ID: 35345947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in a Japanese child.
    Yamaguchi Y; Takasawa K; Irabu H; Hiratoko K; Ichigi Y; Hirata K; Tamura Y; Murakoshi M; Yamashita M; Nakatani H; Shimoda M; Ishii T; Udagawa T; Shimizu M; Kanegane H; Morio T
    J Infect Chemother; 2022 Jun; 28(6):814-818. PubMed ID: 35125343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemolytic uraemic syndrome with peripheral gangrene and Kawasaki disease in a 15-month-old child.
    Krishnamurthy S; Jagadeesh A; Chandrasekaran V; Mahadevan S; Rajesh NG
    Paediatr Int Child Health; 2017 Feb; 37(1):70-73. PubMed ID: 26752398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of refractory Kawasaki disease complicated by peripheral ischemia.
    Kim NY; Choi DY; Jung MJ; Jeon IS
    Pediatr Cardiol; 2008 Nov; 29(6):1110-4. PubMed ID: 18481137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral gangrene in adult-onset Kawasaki disease.
    Bonté I; Mahr A; Laroche L; Guillevin L; Robineau M
    Scand J Rheumatol; 2005; 34(1):71-3. PubMed ID: 15903031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
    Jone PN; Anderson MS; Mulvahill MJ; Heizer H; Glodé MP; Dominguez SR
    Pediatr Infect Dis J; 2018 Oct; 37(10):976-980. PubMed ID: 29461447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kawasaki Shock Syndrome and Covid-19.
    Ashraf S; Abbasi FS; Atiq M
    J Coll Physicians Surg Pak; 2021 Jul; 31(7):135-137. PubMed ID: 34271815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial.
    Burns JC; Roberts SC; Tremoulet AH; He F; Printz BF; Ashouri N; Jain SS; Michalik DE; Sharma K; Truong DT; Wood JB; Kim KK; Jain S;
    Lancet Child Adolesc Health; 2021 Dec; 5(12):852-861. PubMed ID: 34715057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher efficacy of infliximab than immunoglobulin on Kawasaki disease, a meta-analysis.
    Li X; Tang Y; Ding Y; Chen Y; Hou M; Sun L; Qian G; Qin L; Lv H
    Eur J Pharmacol; 2021 May; 899():173985. PubMed ID: 33652059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kawasaki like illness due to COVID-19: a review of the literature.
    Fang Y; Aravamudan VM; Sridharan GK; Mehta KK; Sekhar R; Senguttuvan NB; Venkatachalam I; Abid MB
    J Infect Dev Ctries; 2021 May; 15(5):630-638. PubMed ID: 34106885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab as the First Retreatment in Patients with Kawasaki Disease Resistant to Initial Intravenous Immunoglobulin.
    Youn Y; Kim J; Hong YM; Sohn S
    Pediatr Infect Dis J; 2016 Apr; 35(4):457-9. PubMed ID: 26673981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials.
    Lei WT; Chang LS; Zeng BY; Tu YK; Uehara R; Matsuoka YJ; Su KP; Lee PC; Cavalcante JL; Stubbs B; Lin PY; Wu YC; Hsu CW; Chen TY; Chen YW; Yeh PY; Sun CK; Tseng PT; Kao YH
    EBioMedicine; 2022 Apr; 78():103946. PubMed ID: 35306339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment.
    Abdel-Haq N; Asmar BI; Deza Leon MP; McGrath EJ; Arora HS; Cashen K; Tilford B; Charaf Eddine A; Sethuraman U; Ang JY
    Eur J Pediatr; 2021 May; 180(5):1581-1591. PubMed ID: 33452570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 5-year-old boy with only fever and giant coronary aneurysms: the enigma of Kawasaki disease?
    Vignesh P; Bhattad S; Singhal M; Singh S
    Rheumatol Int; 2016 Aug; 36(8):1191-3. PubMed ID: 27154559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Sri Lankan infant with immunoglobulin resistant incomplete Kawasaki disease with a vesicular psoriasiform rash, hypertension and late onset small joint arthritis: a case report.
    Hoole TJ; Athapathu AS; Abeygunawardene AD
    BMC Pediatr; 2022 Jul; 22(1):444. PubMed ID: 35870915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-valvulitis in Children With Kawasaki Disease: A Case Report and Review of the Literature.
    Leon-Jimenez P; Lorenzo-Martin M; Tomatis-Souverbielle C; Akoghlanian S; Cripe L; Ramilo O; Mejias A
    Pediatr Infect Dis J; 2024 Mar; 43(3):e100-e103. PubMed ID: 38063514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kawasaki disease shock syndrome: Unique and severe subtype of Kawasaki disease.
    Gamez-Gonzalez LB; Moribe-Quintero I; Cisneros-Castolo M; Varela-Ortiz J; Muñoz-Ramírez M; Garrido-García M; Yamazaki-Nakashimada M
    Pediatr Int; 2018 Sep; 60(9):781-790. PubMed ID: 29888440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incomplete and atypical Kawasaki disease in a young infant: severe, recalcitrant disease responsive to infliximab.
    O'connor MJ; Saulsbury FT
    Clin Pediatr (Phila); 2007 May; 46(4):345-8. PubMed ID: 17475994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incomplete Kawasaki Disease as Presentation of COVID-19 Infection in an Infant: A Case Report.
    Raut S; Roychowdhoury S; Bhakta S; Sarkar M; Nandi M
    J Trop Pediatr; 2021 Jul; 67(3):. PubMed ID: 32756980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infantile Kawasaki disease and peripheral gangrene.
    Durall AL; Phillips JR; Weisse ME; Mullett CJ
    J Pediatr; 2006 Jul; 149(1):131-3. PubMed ID: 16860142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.